BBIO
BridgeBio Pharma, Inc. Common Stock
$83.28
-0.97%
-0.81
Notify me if price changes either direction
Buy BBIO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
16.5B
Enterprise value
17.8B
Trailing PE
-22.039682539683
Forward PE
142.4892
PEG Ratio
4.8487301587302
Enterprise to EBITDA
-35.747
Enterprise to revenue
30.75
Price to book MRQ
-7.1524197318363
Price to sales TTM
28.39856
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
580.0M
EBITDA
-498881984
Diluted EPS TTM
-3.78
Total Cash (MRQ)
940.2M
Current ratio (MRQ)
1.521
Operating Cash Flow (TTM)
-443953984
BBIO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
